Glenmark's current portfolio consists of 174 products authorized for distribution in the U.S. marketplace and 48 ANDA's pending approval with the USFDA
The increase in PAT is driven by higher sales and lower marketing and depreciation charge vs the same period last year
While Pregabalin will be manufactured at the Aurangabad facility, Iloperidone will be manufactured at the Goa facility
Ranked 25th with an impressive growth rate of 29% among Indian pharma companies in FY 2021-22
Demand for pharmacies contribute to 52% of the total searches, vaccination centres 30%
The approved product has a market size of US $ 1172 million for the twelve months ending March 2022, according to IQVIA
The inspection report contains no 'critical' observations and only one of the deficiencies is categorized as 'major' which is being addressed expeditiously in consultation with the regulatory agency
Bortezomib for injection is used to treat certain types of cancer such as multiple myeloma and mantle cell lymphoma
Blood test for early detection of Alzheimer's Disease (AD) risk will lead to better patient care, physicians say; US. adults call for earlier evaluation and more education
Submission to regulators globally is based on phase 2/3 studies of mRNA-1273 in young children
Subscribe To Our Newsletter & Stay Updated
